Patent details

Basic Information

Publication number:

92338

Type:

SPC

SPC Type:

Medical

Basic Patent Number:

EP067488635

Legal Status:

Inactive

Application number:

92338

First applicant's nationality:

Procedural language:

French

Marketing Authorization

Marketing Authorization Number:

EU/1/13/846 - XTANDI - enzalutamide

Marketing Authorization Type:

Marketing Authorization Date:

25/06/2013

Marketing Authorization Status:

Accepted

Marketing Authorization Country:

Dates

Filing date:

17/12/2013

First Marketing Authorization date:

25/06/2013

Grant date:

27/10/2015

Activation date:

Publication date:

27/10/2015

Lapsed date:

Expiration date:

Renunciation date:

Revocation date:

Annulment date:

Basic SPC Expiration:

25/06/2028

SPC Extension Expiration:

25/06/2028

Rejection date:

Withdrawal date:

Owner

From:

17/12/2013

 

 

Name:

The Regents of The University of California

Address:

12th Floor 1111 Franklin Street, Oakland, CA 94607-5200, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

17/12/2013

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

CHEN Charlie D.

Address:

United States (US)

2

Name:

JUNG Michael E.

Address:

United States (US)

3

Name:

TRAN Chris

Address:

United States (US)

4

Name:

SAWYERS Charles L.

Address:

United States (US)

5

Name:

OUK Samedy

Address:

United States (US)

6

Name:

WELSBIE Derek

Address:

United States (US)

7

Name:

YOO Dongwon

Address:

United States (US)

8

Name:

WONGVIPAT John

Address:

United States (US)

Annual Fees

Annual Fee Due Date:

31/03/2026

Annual Fee Number:

21

Annual Fee Amount:

410 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages